Comparing the Safety and Efficacy of Celecoxib for the Treatment of Osteoarthritis in Asian and non-Asian Populations: An Analysis of Data from Two Randomized, Double-blind, Placebo-controlled, Active-comparator Trials

[1] Bensen WG(1999)Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial Mayo Clin Proc 74 1095-1105

[2] Fiechtner JJ(2001)Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip J Int Med Res 29 467-479

[3] McMillen JI(2000)Treatment of osteoarthritis with a once-daily dosing regimen of celecoxib: a randomized, controlled trial J Clin Rheumatol. 6 65-74

[4] Kivitz AJ(2012)Response to nonsteroidal anti-inflammatory drugs in African Americans with osteoarthritis of the knee J Int Med Res 40 2251-2266

[5] Moskowitz RW(2016)Efficacy and safety of nonsteroidal anti-inflammatory drugs in Asian patients with knee osteoarthritis: summary of a randomized, placebo-controlled study Int J Rheum Dis. 19 262-270

[6] Woods E(2014)Efficacy and tolerability of celecoxib and naproxen versus placebo in Hispanic patients with knee osteoarthritis Int J Gen Med. 7 227-235

[7] Williams GW(2014)Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial Curr Med Res Opin 30 2399-2408

[8] Ettlinger RE(2011)Efficacy and safety of the selective cyclooxygenase-2 inhibitor celecoxib in the treatment of rheumatoid arthritis and osteoarthritis in Japan Digestion. 83 108-123

[9] Ruderman EM(1986)Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association Arthritis Rheum 29 1039-1049

[10] Essex MN(2017)Risk of acute myocardial infarction with NSAIDs in real world use: Bayesian meta-analysis of individual patient data BMJ 357 j1909-2529

[1] Bensen WG(1999)Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial Mayo Clin Proc 74 1095-1105

[2] Fiechtner JJ(2001)Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip J Int Med Res 29 467-479

[3] McMillen JI(2000)Treatment of osteoarthritis with a once-daily dosing regimen of celecoxib: a randomized, controlled trial J Clin Rheumatol. 6 65-74

[4] Kivitz AJ(2012)Response to nonsteroidal anti-inflammatory drugs in African Americans with osteoarthritis of the knee J Int Med Res 40 2251-2266

[5] Moskowitz RW(2016)Efficacy and safety of nonsteroidal anti-inflammatory drugs in Asian patients with knee osteoarthritis: summary of a randomized, placebo-controlled study Int J Rheum Dis. 19 262-270

[6] Woods E(2014)Efficacy and tolerability of celecoxib and naproxen versus placebo in Hispanic patients with knee osteoarthritis Int J Gen Med. 7 227-235

[7] Williams GW(2014)Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial Curr Med Res Opin 30 2399-2408

[8] Ettlinger RE(2011)Efficacy and safety of the selective cyclooxygenase-2 inhibitor celecoxib in the treatment of rheumatoid arthritis and osteoarthritis in Japan Digestion. 83 108-123

[9] Ruderman EM(1986)Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association Arthritis Rheum 29 1039-1049

[10] Essex MN(2017)Risk of acute myocardial infarction with NSAIDs in real world use: Bayesian meta-analysis of individual patient data BMJ 357 j1909-2529